Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2008	Quality Improvement Scotland (NHS QIS )	Pemetrexed for the treatment of malignant pleural mesothelioma
2008	HAYES, Inc.	Aminolevulinic acid with photodynamic therapy (ALA-PDT) for warts
2008	HAYES, Inc.	Janus kinase 2 (JAK2) sequence variants (including V617F) for chronic myeloproliferative disorders
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Dabigatran etexilate (Pradaxa) for stroke prevention in atrial fibrillation
2008	Agency for Healthcare Research and Quality (AHRQ)	Behavioral counseling to prevent sexually transmitted infections
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Alemtuzumab (MabCampath®) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate
2008	NIHR Health Technology Assessment programme	A prospective randomized comparison of minor surgery in primary and secondary care
2008	Quality Improvement Scotland (NHS QIS )	Structural neuroimaging in first episode psychosis
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory
2008	HAYES, Inc.	Anodyne Therapy System (Anodyne Therapy LLC) for peripheral neuropathy
2008	HAYES, Inc.	Mobile cardiac outpatient telemetry (MCOT) for home monitoring of cardiac patients
2008	HAYES, Inc.	KRAS sequence variant analysis for non-small cell lung cancer (NSCLC)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Dabigatran etexilate (Pradaxa) for acute symptomatic venous thromboembolism
2008	Agency for Healthcare Research and Quality (AHRQ)	Benefits and harms of prostate-specific cancer screening: an evidence update for the U.S. Preventive Services Task Force
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Atazanavir (Reyataz®) for the treatment of HIV-1 infected adults in combination with other antiretroviral medicinal products: for treatment-experienced patients
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Optimizing diagnosis of recurrent events using (almost) continuous monitoring ancillary study of costs and effects of strategies to prevent oversedation in intensive care patients, nr 80-007022-98-04103]
2008	Quality Improvement Scotland (NHS QIS )	Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2008	HAYES, Inc.	KRAS sequence variant analysis for predicting response to colorectal cancer drug therapy
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Clopidogrel (Plavix) in combination with aspirin for prevention of vascular events in patients with atrial fibrillation
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening for type 2 diabetes: update of 2003 systematic evidence review for the U.S. Preventive Services Task Force
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Atazanavir (Reyataz®) for the treatment of HIV-1 infected adults in combination with other antiretroviral medicinal products: for treatment-naive patients
2008	Quality Improvement Scotland (NHS QIS )	Inhaled corticosteroids for the treatment of chronic asthma in adults and children aged 12 years and over
2008	HAYES, Inc.	Arthroscopic hip surgery for femoroacetabular impingement (FAI)
2008	HAYES, Inc.	LHON (Leber Hereditary Optic Neuropathy) for diagnosis and risk of transmission
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Clevudine (Levovir) for hepatitis B
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening for gestational diabetes mellitus
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Teriparatide (Forsteo®) for the treatment of osteoporosis in men at increased risk of fracture
2008	Quality Improvement Scotland (NHS QIS )	Continuous positive airways pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome
2008	HAYES, Inc.	Methylenetetrahydrofolate Reductase (MTHFR) C677T for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Raltegravir (Isentress®) in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[RCT of point of care C-reactive protein test and enhanced communication skills for managing acute cough due to lower respiratory tract infection in general practice: cost effectiveness and effect on diagnostic testing, antibiotic prescribing and recovery]
2008	Quality Improvement Scotland (NHS QIS )	Infliximab for subacute manifestations for ulcerative colitis
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening in primary care settings for illicit drug use: assessment of screening instruments - a supplemental evidence update for the U.S. Preventive Services Task Force
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Abacavir 600mg/lamivudine 300mg (Kivexa®) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age
2008	NIHR Health Technology Assessment programme	Randomised trial of fluoxetine and cognitive-behavioral therapy versus fluoxetine alone in adolescents with persistent major depression - primary research
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Patient safety/medication safety: the impact of computerized physician order entry on medication error prevention in hospitalized patients]
2008	Quality Improvement Scotland (NHS QIS )	Abatacept for the treatment of rheumatoid arthritis
2008	HAYES, Inc.	PGxPredic: Rituximab Test (PGxHealth) for FCGR3A variants in follicular CD20-positive non-Hodgkin's Lymphoma
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening in primary care settings for illicit drug use: staged systematic review for the U.S. Preventive Services Task Force
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Rufinamide (Inovelon®) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Minimally invasive arthroplasty in the management of hip arthritic disease: systematic review and economic evaluation
2008	Quality Improvement Scotland (NHS QIS )	Tonsillectomy for recurrent bacterial tonsillitis
2008	HAYES, Inc.	Avastin (bevacizumab) for the treatment of ovarian cancer
2008	HAYES, Inc.	Prader-Willi Syndrome (PWS)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	ChondroCelect for knee cartilage defects
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy
2008	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study
2008	Adelaide Health Technology Assessment (AHTA)	Infrared spectroscopy for the diagnosis of acute pancreatitis
2008	HAYES, Inc.	Primary Dystonia Type 1 (DYT1/TOR1A)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Bortezomib for relapsed and/or refractory follicular non-Hodgkins lymphoma
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Icatibant acetate (Firazyr®) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency)
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Systematic care for informal caregivers of dementia patients: an efficient approach?]
2008	Adelaide Health Technology Assessment (AHTA)	Rapid breath test for assessing total body water in chronic kidney disease patients
2008	HAYES, Inc.	Prothrombin G20210A for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) for glioblastoma multiforme - relapsed
2008	Agency for Healthcare Research and Quality (AHRQ)	Screening for lipid disorders in adults: selective update of 2001 U.S. Preventive Services Task Force review
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tacrolimus prolonged-release (Advagraf®)
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery]
2008	Adelaide Health Technology Assessment (AHTA)	Spinal cord stimulation treatment for cardiac syndrome X
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Belatacept for prophylaxis of organ rejection in renal transplantation
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence]
2008	Adelaide Health Technology Assessment (AHTA)	Scalable Medical Alert Response Technology (SMART) for monitoring emergency department patients
2008	HAYES, Inc.	Bexxar (tositumomab and iodine-131 tositumomab) (GlaxoSmithKline) for treatment of refractory or relapsed non-Hodgkin's lymphoma (NHL)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	AVE-5026 for the prevention of venous thromboembolism in patients at risk
2008	Adelaide Health Technology Assessment (AHTA)	Optical coherence tomography for MS prognosis
2008	HAYES, Inc.	NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for the prevention of bleeding in patients with congenital hemophilia A or B (Factor VIII or IX deficiency hemophilia)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Apixaban for prevention of venous thromboembolism after joint replacement or with acute medical illness
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The treatment of depression in primary care: the efficiency of computerised cognitive behaviour therapy]
2008	Adelaide Health Technology Assessment (AHTA)	MR colonography for bowel cancer diagnosis
2008	HAYES, Inc.	BioniCare knee device (ArthroWave Medical Technologies LLC) for osteoarthritis of the knee
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Ticagrelor (AZD6140) for acute coronary syndrome
2008	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of therapies for clinically localized prostate cancer
2008	Adelaide Health Technology Assessment (AHTA)	MRI diagnosis of rheumatoid arthritis
2008	HAYES, Inc.	Biopatch antimicrobial dressing (Integra LifeSciences Corp. and Ethicon Inc., a division of Johnson & Johnson Co.) for prevention of catheter- and device-related bloodstream infections
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Panitumumab (Vectibix) for first-line metastatic colorectal cancer
2008	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness, safety, and indications of insulin analogues in premixed formulations for adults with type 2 diabetes
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[What is the (cost-) effectiveness of a multidisciplinary treatment program for patients with clinically manifest vascular disease or at high risk for atherosclerosis on risk factor reduction?]
2008	Adelaide Health Technology Assessment (AHTA)	Impedimed ImpTM for diagnosis of lymphodema
2008	HAYES, Inc.	Thrombosis panel for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Nilotinib (Tasigna) for gastrointestinal stromal tumours
2008	Adelaide Health Technology Assessment (AHTA)	Magnetic resonance imaging (MRI) for the diagnosis of pulmonary embolism
2008	HAYES, Inc.	Pentacel (Sanofi Pasteur Ltd.) for active immunization of infants and children
2008	HAYES, Inc.	Uniparental disomy (UPD) for chromosomes 6, 7, 11, 14, or 15
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Nilotinib (Tasigna) for chronic myeloid leukaemia
2008	Adelaide Health Technology Assessment (AHTA)	Point of care testing for Coeliac disease
2008	HAYES, Inc.	Botulinum toxin treatment for gastroparesis
2008	HAYES, Inc.	Y chromosome microdeletions in male infertility
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis
2008	Adelaide Health Technology Assessment (AHTA)	Quantitative ultrasound (QUS) for predicting bone fracture. Horizon scanning report
2008	HAYES, Inc.	Bryan cervical disc system (Medtronic Sofamor Danek) for degenerative disc disease
2008	HAYES, Inc.	Percutaneous cryoablation for treatment of renal cell cancer
2008	HAYES, Inc.	Gene expression profiling for prognosis of recurrence of primary breast cancer
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Mepolizumab (Bosatria) for hypereosinophilic syndrome - first line in combination with corticosteroids
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Pegfilgrastim (Neulasta®) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy
2008	Adelaide Health Technology Assessment (AHTA)	Bone mineral testing. Systematic review
2008	HAYES, Inc.	Calypso 4D localization system (Calypso Medical Technologies Inc.) for guidance of prostate cancer radiation therapy
2008	HAYES, Inc.	Ashkenazi Jewish genetic carrier screening panel
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Icatibant (Firazyr) for acute hereditary angioedema
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Trabectedin (Yondelis®) for advanced soft tissue sarcoma